Department of Obstetrics, Division of Endocrinology and Metabolism, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, No 251, Yaojiayuan Road, Chaoyang District, Beijing, 100026, China.
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, USA.
BMC Pregnancy Childbirth. 2021 Mar 17;21(1):216. doi: 10.1186/s12884-021-03690-z.
Gestational diabetes mellitus (GDM) and excessive body weight are two key risk factors for adverse perinatal outcomes. However, it is not clear whether restricted gestational weight gain (GWG) is favorable to reduce the risk for adverse pregnancy and neonatal outcomes in women with GDM. Therefore, this study aimed to assess the association of GWG after an oral glucose tolerance test with maternal and neonatal outcomes.
This prospective cohort study assessed the association of GWG after an oral glucose tolerance test (OGTT) with pregnancy and neonatal outcomes in 3126 women with GDM, adjusted for age, pre-pregnancy body mass index, height, gravidity, parity, adverse history of pregnancy, GWG before OGTT, blood glucose level at OGTT and late pregnancy. The outcomes included the prevalence of pregnancy-induced hypertension (PIH) and preeclampsia, large for gestational age (LGA), small for gestational age, macrosomia, low birth weight, preterm birth, and birth by cesarean section. GDM was diagnosed according to the criteria established by the International Association of Diabetes and Pregnancy Study Groups.
GWG after OGTT was positively associated with risk for overall adverse pregnancy outcomes (adjusted odds ratio [aOR] = 1.72, 95% confidence interval [CI] = 1.50-1.97), LGA (aOR = 1.29, 95%CI = 1.13-1.47), macrosomia (aOR = 1.24, 95%CI = 1.06-1.46) and birth by cesarean section (aOR = 1.91, 95%CI = 1.67-2.19) in women with GDM. Further analyses revealed that a combination of excessive GWG before OGTT and after OGTT increased the risk of PIH and preeclampsia, LGA, macrosomia, and birth by cesarean section compared with adequate GWG throughout pregnancy. In contrast, GWG below the Institute of Medicine guideline after OGTT did not increase the risk of adverse perinatal outcomes despite GWG before OGTT.
Excessive GWG after OGTT was associated with an elevated risk of adverse pregnancy outcomes, while insufficient GWG after OGTT did not increase the risk of LBW. Restricting GWG after diagnosis of GDM in women with excessive GWG in the first half of pregnancy may be beneficial to prevent PIH and preeclampsia, LGA, macrosomia, and birth by cesarean section.
妊娠糖尿病(GDM)和超重是不良围产期结局的两个关键危险因素。然而,目前尚不清楚限制妊娠期体重增加(GWG)是否有利于降低 GDM 女性的妊娠和新生儿不良结局风险。因此,本研究旨在评估口服葡萄糖耐量试验(OGTT)后 GWG 与母婴结局的关系。
这项前瞻性队列研究评估了 3126 例 GDM 女性 OGTT 后 GWG 与妊娠和新生儿结局的关系,调整了年龄、孕前 BMI、身高、孕次、产次、不良妊娠史、OGTT 前 GWG、OGTT 时血糖水平和晚期妊娠。结局包括妊娠高血压(PIH)和子痫前期、巨大儿、小于胎龄儿、巨大儿、低出生体重儿、早产和剖宫产分娩的发生率。GDM 按照国际糖尿病与妊娠研究协会制定的标准诊断。
OGTT 后 GWG 与不良妊娠结局的总体风险呈正相关(调整后的优势比[aOR] = 1.72,95%置信区间[CI] = 1.50-1.97)、巨大儿(aOR = 1.29,95%CI = 1.13-1.47)和剖宫产分娩(aOR = 1.91,95%CI = 1.67-2.19)。进一步分析显示,OGTT 前和 OGTT 后 GWG 过度增加了与整个孕期 GWG 充足相比 PIH 和子痫前期、巨大儿、巨大儿和剖宫产分娩的风险。相比之下,OGTT 后低于美国医学研究所指南的 GWG 尽管 OGTT 前 GWG 不足,但并未增加不良围产期结局的风险。
OGTT 后 GWG 过度与不良妊娠结局风险增加相关,而 OGTT 后 GWG 不足不会增加 LBW 风险。对于妊娠前半期 GWG 过度的 GDM 女性,限制诊断后 GWG 可能有利于预防 PIH 和子痫前期、巨大儿、巨大儿和剖宫产分娩。